OneMedNet Corp (ONMD)

Data as of Oct 14, 2026, from SEC Form 4 filings.

NasdaqServices-Commercial Physical & Biological ResearchNet insider buying (90d)Watch ONMD

See up to 3 months of ONMD. The 7-day demo opens the 1M and 3M ranges and puts ONMD on your watchlist.

Latest ONMD insider trades

Thomas Kosasa - Director
Open-market purchase$750K
Oct 7, 2026

About OneMedNet Corp (ONMD)

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.

Headquarters: SURREY, X0
Employees: 23
Listed: 2023
Exchange: Nasdaq
Sector: Health Care

https://www.onemednet.com SEC filings for ONMD on EDGAR

ONMD Form 4 activity by transaction type, last 90 days

Form 4 transaction type	Transactions	Shares	Total value
Open-market purchase	4	1,767,016	$2.09M
Open-market sale	5	15,167	$103K
Grant or award	3	110,000

Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.

ONMD insider transactions (Form 4)

113

25 Form 4 filings on record, the earliest from Nov 26, 2025, newest first.

Traded	Insider	Transaction	Security	Shares	Price	Value
Oct 7, 2026	Thomas Kosasa - Director	Open-market purchase	Common Stock	129,758	$5.78^{footnote F2}	$750K
Footnote F2 (price): The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date.
Oct 9, 2026	Jeffrey Yu - Officer	Open-market purchase	Common Stock	45,126	$5.54^{footnote F2}	$250K
Footnote F2 (price): The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date.
Jan 1, 2026	Robert Lawrence Golden - Officer	Grant or award	Common Stock	10,000^{footnote F1,F3}	$0.00	-
Jul 6, 2026	Robert Lawrence Golden - Officer	Grant or award	Common Stock	35,000^{footnote F2,F3}	$0.00	-
Sep 14, 2026	Robert Lawrence Golden - Officer	Open-market sale	Common Stock	2,500	$66.00	$17K
Sep 15, 2026	Robert Lawrence Golden - Officer	Open-market sale	Common Stock	3,000	$63.00	$19K
Sep 21, 2026	Robert Lawrence Golden - Officer	Open-market sale	Common Stock	3,000	$66.30	$20K
Footnote F1 (shares): Represents restricted stock units ("RSUs") granted pursuant to contractor arrangements with the reporting person. The RSUs vest in full on December 31, 2026, subject to the terms of Section 7.2.2 of the Consulting Agreement, dated January 1, 2026, between the issuer and Mr… Full note on SEC EDGAR Footnote F2 (shares): Represents RSUs granted pursuant to contractor arrangements with the reporting person. The RSUs vest with respect to 1/3 of the shares on the first anniversary of the vesting start date of January 1, 2026, with the remaining RSUs vesting in equal quarterly installments on the… Full note on SEC EDGAR Footnote F3 (shares): Each RSU represents the contingent right to receive one share of the issuer's common stock.
Jul 6, 2026	Aaron Green - Officer	Grant or award	Common Stock	65,000^{footnote F1,F2}	$0.00	-
Sep 22, 2026	Aaron Green - Officer	Open-market sale	Common Stock	5,000	$73.92	$37K
Sep 24, 2026	Aaron Green - Officer	Open-market sale	Common Stock	1,667	$64.80	$11K
Footnote F1 (shares): Represents Restricted Stock Units ("RSUs") granted to the reporting person under the OneMedNet Corporation 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the issuer's common stock. The RSUs vest with respect to 1/3 of the shares on… Full note on SEC EDGAR Footnote F2 (shares): All share amounts and share prices shown in this report have been adjusted to reflect the 1-for-10 reverse stock split by the issuer on September 29, 2026.
Sep 10, 2026	Jeffrey Yu - Officer	Open-market purchase	Common Stock	142,857	$0.63^{footnote F2}	$90K
Footnote F2 (price): The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date.
Jul 30, 2026	Thomas Kosasa - Director	Open-market purchase	Common Stock	1,449,275	$0.69^{footnote F2}	$1.00M
Footnote F2 (price): The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date.
Jun 23, 2026	Aaron Green - Officer	Open-market purchase	Common Stock	36,650	$5.73	$21K
Jun 23, 2026	Jeffrey Yu - Officer	Open-market purchase	Common Stock	158,730	$6.30	$100K
Jun 16, 2026	Jeffrey Yu - Officer	Open-market purchase	Common Stock	172,414	$5.80	$100K
Jun 15, 2026	Aaron Green - Officer	Open-market purchase	Common Stock	18,702	$5.40	$10K
Jun 12, 2026	Aaron Green - Officer	Open-market purchase	Common Stock	36,920	$0.56^{footnote F1}	$21K
Footnote F1 (price): The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.5463 to $0.5625, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the… Full note on SEC EDGAR
Jun 12, 2026	Thomas Kosasa - Director	Open-market purchase	Common Stock	158,730	$0.63^{footnote F2}	$100K
Footnote F2 (price): The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date.
May 18, 2026	Thomas Kosasa - Director	Open-market purchase	Common Stock	268,817	$0.93^{footnote F2}	$250K
Footnote F2 (price): The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date.
Apr 1, 2026	Jeffrey Yu - Officer	Open-market purchase	Common Stock	903,614	$8.30	$750K
Apr 1, 2026	Jeffrey Yu - Officer	Grant or award	Common Stock	219,429	$8.30	$182K
Feb 6, 2026	Thomas Kosasa - Director	Open-market purchase	Common Stock	595,238	$0.84^{footnote F2}	$500K
Apr 23, 2026	Thomas Kosasa - Director	Open-market purchase	Common Stock	280,898	$0.89^{footnote F2}	$250K
Footnote F2 (price): The shares were valued at the volume-weighted average price for the 10 trading days immediately prior to the applicable purchase date.
Oct 22, 2025	Aaron Green - Officer	Open-market sale	Common Stock	64,767	$22.35	$145K
Nov 18, 2025	Aaron Green - Officer	Open-market sale	Common Stock	61,555	$12.01	$74K
Jun 17, 2025	Jeffrey Yu - Officer	Other	Common Stock	479,270	$11.40	$546K
Jun 19, 2025	Jeffrey Yu - Officer	Other	Common Stock	1,828,279	$7.10	$1.30M
Jun 20, 2025	Jeffrey Yu - Officer	Open-market purchase	Common Stock	1,666,666	$4.20	$700K
Aug 19, 2025	Jeffrey Yu - Officer	Open-market purchase	Common Stock	16,500	$7.70	$13K
Aug 21, 2025	Jeffrey Yu - Officer	Open-market purchase	Common Stock	15,000	$7.70	$12K
Aug 25, 2025	Jeffrey Yu - Officer	Open-market purchase	Common Stock	13,300	$7.50	$10K
Aug 26, 2025	Jeffrey Yu - Officer	Open-market purchase	Common Stock	173,350	$6.90	$120K
Aug 27, 2025	Jeffrey Yu - Officer	Open-market purchase	Common Stock	21,374	$6.90	$15K
Aug 28, 2025	Jeffrey Yu - Officer	Open-market purchase	Common Stock	17,000	$8.00	$14K
Aug 29, 2025	Jeffrey Yu - Officer	Open-market purchase	Common Stock	10,890	$8.20	$9K
Sep 2, 2025	Jeffrey Yu - Officer	Open-market purchase	Common Stock	24,319	$8.50	$21K
Sep 3, 2025	Jeffrey Yu - Officer	Open-market purchase	Common Stock	11,670	$8.10	$9K
Sep 4, 2025	Jeffrey Yu - Officer	Open-market purchase	Common Stock	11,810	$8.70	$10K
Sep 5, 2025	Jeffrey Yu - Officer	Open-market purchase	Common Stock	2,100	$8.60	$2K
Sep 18, 2025	Jeffrey Yu - Officer	Open-market purchase	Common Stock	700	$9.10	$637
Sep 19, 2025	Jeffrey Yu - Officer	Open-market purchase	Common Stock	1,250	$8.90	$1K
Sep 22, 2025	Jeffrey Yu - Officer	Open-market purchase	Common Stock	400	$9.50	$380
Sep 23, 2025	Jeffrey Yu - Officer	Open-market purchase	Common Stock	5,700	$9.30	$5K
Sep 24, 2025	Jeffrey Yu - Officer	Open-market purchase	Common Stock	17,200	$10.20	$18K
Sep 25, 2025	Jeffrey Yu - Officer	Open-market purchase	Common Stock	1,250	$10.30	$1K
Nov 24, 2025	Jeffrey Yu - Officer	Grant or award	Common Stock	200,000	$0.00	-
Nov 26, 2025	Jeffrey Yu - Officer	Grant or award	Common Stock	45,000	$0.00	-
Jun 17, 2025	Jeffrey Yu - Officer	Other	Senior Secured Convertible Note	479,270	$11.40	$546K
May 9, 2025	Jeffrey Yu - Officer	Open-market purchase	Warrants (Right to Buy	5,946	$0.30	$178
Apr 21, 2025	Thomas Kosasa - Director	Open-market purchase	Common Stock	47,000	$4.86	$23K
Jun 16, 2025	Thomas Kosasa - Director	Open-market purchase	Common Stock	55,000	$3.82	$21K
Jan 19, 2024	Thomas Kosasa - Director	Grant or award	Common Stock	45,000^{footnote F1}	$0.00	-
Sep 24, 2025	Thomas Kosasa - Director	Open-market purchase	Common Stock	6,000	$9.33	$6K
Jun 20, 2025	Thomas Kosasa - Director	Open-market purchase	Common Stock	1,190,476^{footnote F5}	$4.20	$500K
Aug 29, 2025	Thomas Kosasa - Director	Open-market purchase	Common Stock	581,395^{footnote F6}	$8.60	$500K
Nov 26, 2025	Thomas Kosasa - Director	Grant or award	Common Stock	45,000^{footnote F7}	$0.00	-
Jun 17, 2025	Thomas Kosasa - Director	Other	Common Stock	493,056^{footnote F2}	$11.40	$562K
Jun 19, 2025	Thomas Kosasa - Director	Other	Common Stock	2,123,424^{footnote F3}	$7.53	$1.60M
Jun 19, 2025	Thomas Kosasa - Director	Other	Common Stock	2,865,016^{footnote F4}	$7.10	$2.03M
Jun 17, 2025	Thomas Kosasa - Director	Other	Senior Secured Convertible Note	493,056	-^{footnote F2}	-
Footnote F1 (shares): Represents restricted stock units ("RSUs") granted as director compensation under the OneMedNet Corporation 2022 Equity Incentive Plan (the "2022 Plan") for board service in fiscal year 2024. Each RSU represents the contingent right to receive one share of the issuer's common… Full note on SEC EDGAR Footnote F2 (shares, price): On June 28, 2023, Data Knights Acquisition Corp. ("Data Knights") (the predecessor of the issuer) and certain investors, including the reporting person (collectively, the "Purchasers"), entered into a securities purchase agreement pursuant to which Data Knights issued and sold… Full note on SEC EDGAR Footnote F3 (shares): On June 19, 2025, the reporting person delivered notice of his election to convert in full the amounts of outstanding principal under certain convertible shareholder loans previously made by the reporting person to the issuer, in an aggregate principal amount of approximately… Full note on SEC EDGAR Footnote F4 (shares): On June 19, 2025, the issuer entered into an agreement with the reporting person to convert an aggregate of approximately $2.0 million of outstanding principal and accrued interest under certain shareholder loans and business combination extension loans. Footnote F5 (shares): On June 20, 2025, the issuer entered into a subscription agreement with the reporting person, pursuant which the issuer agreed to sell 1,190,476 shares of common stock to the reporting person at a purchase price of $0.42 per share, totaling $500,000 in gross proceeds to the… Full note on SEC EDGAR Footnote F6 (shares): On August 29, 2025, the issuer entered into a subscription agreement with the reporting person, pursuant to which the issuer agreed to sell 581,395 shares of common stock to the reporting person at a purchase price of $0.86 per share, totaling $500,000 in gross proceeds to the… Full note on SEC EDGAR Footnote F7 (shares): Represents RSUs granted as director compensation under the 2022 Plan for board service in fiscal year 2025. The RSUs vest on December 31, 2025, subject to the reporting person's continued service with the issuer through the vesting date.
Jan 19, 2024	Aaron Green - Officer	Grant or award	Common Stock	45,000^{footnote F1}	$0.00	-
Jun 17, 2025	Aaron Green - Officer	Other	Common Stock	240,425^{footnote F2}	$11.40	$274K
Nov 24, 2025	Aaron Green - Officer	Grant or award	Common Stock	1,000,000^{footnote F3}	$0.00	-
Nov 26, 2025	Aaron Green - Officer	Grant or award	Common Stock	45,000^{footnote F4}	$0.00	-
Jun 17, 2025	Aaron Green - Officer	Other	Senior Secured Convertible Note	240,425	-^{footnote F2}	-
Footnote F1 (shares): Represents restricted stock units ("RSUs") granted as director compensation under the OneMedNet Corporation 2022 Equity Incentive Plan (the "2022 Plan") for board service in fiscal year 2024. Each RSU represents the contingent right to receive one share of the issuer's common… Full note on SEC EDGAR Footnote F2 (shares, price): On June 28, 2023, Data Knights Acquisition Corp. ("Data Knights") (the predecessor of the issuer) and certain investors, including the reporting person (collectively, the "Purchasers"), entered into a securities purchase agreement pursuant to which Data Knights issued and sold… Full note on SEC EDGAR Footnote F3 (shares): Represents RSUs granted under the 2022 Plan as employment compensation for fiscal years 2024 and 2025. The RSUs vest with respect to 47% of the RSUs on the first anniversary of the vesting start date of January 1, 2025, with the remaining RSUs vesting on the last day of each… Full note on SEC EDGAR Footnote F4 (shares): Represents RSUs granted as director compensation under the 2022 Plan for board service in fiscal year 2025. The RSUs vest on December 31, 2025, subject to the reporting person's continued service with the issuer through the vesting date.
Feb 16, 2024	Eric Casaburi - Director	Open-market purchase	Common Stock	2,000	$7.70	$2K
Feb 29, 2024	Eric Casaburi - Director	Open-market purchase	Common Stock	575	$7.20	$414
Mar 5, 2024	Eric Casaburi - Director	Open-market purchase	Common Stock	2,000	$7.40	$1K
Jul 8, 2024	Eric Casaburi - Director	Open-market purchase	Common Stock	4,100	$9.20	$4K
Nov 12, 2024	Eric Casaburi - Director	Open-market purchase	Common Stock	500	$8.50	$425
Nov 20, 2024	Eric Casaburi - Director	Open-market purchase	Common Stock	1,300	$8.70	$1K
Oct 15, 2025	Eric Casaburi - Director	Open-market purchase	Common Stock	10,000	$30.50	$31K
Jan 19, 2024	Eric Casaburi - Director	Grant or award	Common Stock	45,000^{footnote F1}	$0.00	-
Nov 26, 2025	Eric Casaburi - Director	Grant or award	Common Stock	45,000^{footnote F2}	$0.00	-
Footnote F1 (shares): Represents restricted stock units ("RSUs") granted as director compensation under the OneMedNet Corporation 2022 Equity Incentive Plan (the "2022 Plan") for board service in fiscal year 2024. Each RSU represents the contingent right to receive one share of the issuer's common… Full note on SEC EDGAR Footnote F2 (shares): Represents RSUs granted as director compensation under the 2022 Plan for board service in fiscal year 2025. The RSUs vest on December 31, 2025, subject to the reporting person's continued service with the issuer through the vesting date.
Oct 1, 2024	Sherry Coonse McCraw - Director	Grant or award	Common Stock	11,342^{footnote F1}	$0.00	-
Nov 26, 2025	Sherry Coonse McCraw - Director	Grant or award	Common Stock	45,000^{footnote F2}	$0.00	-
Footnote F1 (shares): Represents restricted stock units ("RSUs") granted as director compensation under the OneMedNet Corporation 2022 Equity Incentive Plan (the "2022 Plan") for board service in fiscal year 2024. Each RSU represents the contingent right to receive one share of the issuer's common… Full note on SEC EDGAR Footnote F2 (shares): Represents RSUs granted as director compensation under the 2022 Plan for board service in fiscal year 2025. The RSUs vest on December 31, 2025, subject to the reporting person's continued service with the issuer through the vesting date.
Oct 1, 2024	Jair Clarke - Director	Grant or award	Common Stock	11,342^{footnote F1}	$0.00	-
Jan 1, 2025	Jair Clarke - Director	Grant or award	Common Stock	82,143^{footnote F2}	$0.00	-
Nov 26, 2025	Jair Clarke - Director	Grant or award	Common Stock	45,000^{footnote F3}	$0.00	-
Footnote F1 (shares): Represents restricted stock units ("RSUs") granted as director compensation under the OneMedNet Corporation 2022 Equity Incentive Plan (the "2022 Plan") for board service in fiscal year 2024. Each RSU represents the contingent right to receive one share of the issuer's common… Full note on SEC EDGAR Footnote F2 (shares): Represents RSUs granted as director compensation under the 2022 Plan for service on the Commercial Committee. The RSUs vest as follows: (i) 50% of the RSU vest quarterly on the last day of each quarter for the applicable calendar year, subject to the reporting person's continued… Full note on SEC EDGAR Footnote F3 (shares): Represents RSUs granted as director compensation under the 2022 Plan for board service in fiscal year 2025. The RSUs vest on December 31, 2025, subject to the reporting person's continued service with the issuer through the vesting date.
Nov 26, 2025	Kenneth Alleyne - Director	Grant or award	Common Stock	38,219^{footnote F1}	$0.00	-
Footnote F1 (shares): Represents restricted stock units ("RSUs") granted as director compensation under the OneMedNet Corporation 2022 Equity Incentive Plan for board service in fiscal year 2025. Each RSU represents the contingent right to receive one share of the issuer's common stock. The RSUs vest… Full note on SEC EDGAR
Dec 13, 2023	Jeffrey Yu - Officer	Open-market purchase	Common Stock	50	$10.90	$55
Dec 15, 2023	Jeffrey Yu - Officer	Open-market purchase	Common Stock	10	$9.20	$9
Dec 27, 2023	Jeffrey Yu - Officer	Open-market purchase	Common Stock	10	$10.30	$10
Jan 2, 2024	Jeffrey Yu - Officer	Open-market purchase	Common Stock	20	$8.20	$16
Jan 8, 2024	Jeffrey Yu - Officer	Open-market purchase	Common Stock	10	$8.30	$8
Jan 9, 2024	Jeffrey Yu - Officer	Open-market purchase	Common Stock	100	$8.60	$86
Jan 10, 2024	Jeffrey Yu - Officer	Open-market purchase	Common Stock	20	$8.50	$17
Jan 12, 2024	Jeffrey Yu - Officer	Open-market purchase	Common Stock	20	$8.10	$16
Dec 8, 2023	Jeffrey Yu - Officer	Open-market purchase	Common Stock	3,300	$1.31^{footnote F1}	$4K
Dec 11, 2023	Jeffrey Yu - Officer	Open-market purchase	Common Stock	30	$1.36^{footnote F2}	$41
Dec 12, 2023	Jeffrey Yu - Officer	Open-market purchase	Common Stock	3,040	$1.06^{footnote F3}	$3K
Jan 4, 2024	Jeffrey Yu - Officer	Open-market purchase	Common Stock	180	$0.84^{footnote F4}	$151
Jan 16, 2024	Jeffrey Yu - Officer	Open-market purchase	Common Stock	15	$0.75^{footnote F5}	$11
Jan 17, 2024	Jeffrey Yu - Officer	Open-market purchase	Common Stock	362	$0.61^{footnote F6}	$221
Jan 19, 2024	Jeffrey Yu - Officer	Open-market purchase	Common Stock	60	$0.48^{footnote F7}	$29
Jan 19, 2024	Jeffrey Yu - Officer	Grant or award	Common Stock	45,000^{footnote F15}	$0.00	-
Jan 22, 2024	Jeffrey Yu - Officer	Open-market purchase	Common Stock	5,035	$0.49^{footnote F8}	$2K
Jan 23, 2024	Jeffrey Yu - Officer	Open-market purchase	Common Stock	720	$0.52^{footnote F9}	$374
Jan 24, 2024	Jeffrey Yu - Officer	Open-market purchase	Common Stock	740	$0.55^{footnote F10}	$407
Jan 25, 2024	Jeffrey Yu - Officer	Open-market purchase	Common Stock	2,304	$0.55^{footnote F11}	$1K
Jan 26, 2024	Jeffrey Yu - Officer	Open-market purchase	Common Stock	5,386	$0.56^{footnote F12}	$3K
Jan 29, 2024	Jeffrey Yu - Officer	Open-market purchase	Common Stock	950	$1.04^{footnote F13}	$988
Jan 30, 2024	Jeffrey Yu - Officer	Open-market purchase	Common Stock	400	$1.14^{footnote F14}	$456
Footnote F1 (price): The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.28 to $1.31, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the… Full note on SEC EDGAR Footnote F2 (price): The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.35 to $1.37, inclusive. Footnote F3 (price): The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.03 to $1.09, inclusive. Footnote F4 (price): The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.82 to $0.85, inclusive. Footnote F5 (price): The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.71 to $0.78, inclusive. Footnote F6 (price): The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.56 to $0.73, inclusive. Footnote F7 (price): The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.44 to $0.62, inclusive. Footnote F8 (price): The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.44 to $0.62, inclusive. Footnote F9 (price): The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.48 to $0.54, inclusive. Footnote F10 (price): The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.52 to $0.60, inclusive. Footnote F11 (price): The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.50 to $0.60, inclusive. Footnote F12 (price): The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.51 to $0.60, inclusive. Footnote F13 (price): The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.03 to $1.07, inclusive. Footnote F14 (price): The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.03 to $1.48, inclusive. Footnote F15 (shares): Represents restricted stock units ("RSUs") granted as director compensation under the OneMedNet Corporation 2022 Equity Incentive Plan for board service in fiscal year 2024. Each RSU represents the contingent right to receive one share of the issuer's common stock. The RSUs… Full note on SEC EDGAR
Dec 7, 2023	Robert Lawrence Golden - Officer	Open-market purchase	Common Stock	300	$17.10	$513
Jan 19, 2024	Robert Lawrence Golden - Officer	Grant or award	Common Stock	45,000^{footnote F1}	$0.00	-
Aug 30, 2024	Robert Lawrence Golden - Officer	Grant or award	Common Stock	100,000^{footnote F2}	$0.00	-
Jan 31, 2025	Robert Lawrence Golden - Officer	Grant or award	Common Stock	24,272^{footnote F3}	$0.00	-
Nov 24, 2025	Robert Lawrence Golden - Officer	Grant or award	Common Stock	300,000^{footnote F4}	$0.00	-
Nov 24, 2025	Robert Lawrence Golden - Officer	Grant or award	Common Stock	33,333^{footnote F5}	$0.00	-
Nov 26, 2025	Robert Lawrence Golden - Officer	Grant or award	Common Stock	45,000^{footnote F6}	$0.00	-
Footnote F1 (shares): Represents restricted stock units ("RSUs") granted as director compensation under the OneMedNet Corporation 2022 Equity Incentive Plan (the "2022 Plan") for board service in fiscal year 2024. Each RSU represents the contingent right to receive one share of the issuer's common… Full note on SEC EDGAR Footnote F2 (shares): Represents RSUs granted pursuant to a consulting agreement with the reporting person. The RSUs vested on August 30, 2025. Footnote F3 (shares): Represents RSUs granted in lieu of a cash bonus pursuant to contractor arrangements with the reporting person in connection with his appointment as permanent Chief Financial Officer. The RSUs fully vested on the grant date. Footnote F4 (shares): Represents RSUs granted pursuant to contractor arrangements with the reporting person. The RSUs vest with respect to 1/3 of the shares on the first anniversary of the vesting start date of January 1, 2025, with the remaining RSUs vesting in equal quarterly installments on the… Full note on SEC EDGAR Footnote F5 (shares): Represents RSUs granted pursuant to contractor arrangements with the reporting person. The RSUs vest in full on December 31, 2025, subject to the terms of Section 7.2.2 of the Consulting Agreement, dated August 30, 2024, between the issuer and Mr. Golden. Footnote F6 (shares): Represents RSUs granted as director compensation under the 2022 Plan for board service in fiscal year 2025. The RSUs vest on December 31, 2025, subject to the reporting person's continued service with the issuer through the vesting date.
Aug 14, 2024	Andrew B. Zeinfeld - Director	Grant or award	Common Stock	17,260^{footnote F1}	$0.00	-
Jan 1, 2025	Andrew B. Zeinfeld - Director	Grant or award	Common Stock	82,143^{footnote F2}	$0.00	-
Nov 26, 2025	Andrew B. Zeinfeld - Director	Grant or award	Common Stock	45,000^{footnote F3}	$0.00	-
Footnote F1 (shares): Represents restricted stock units ("RSUs") granted as director compensation under the OneMedNet Corporation 2022 Equity Incentive Plan (the "2022 Plan") for board service in fiscal year 2024. Each RSU represents the contingent right to receive one share of the issuer's common… Full note on SEC EDGAR Footnote F2 (shares): Represents RSUs granted as director compensation under the 2022 Plan for service on the Commercial Committee. The RSUs vest as follows: (i) 50% of the RSU vest quarterly on the last day of each quarter for the applicable calendar year, subject to the reporting person's continued… Full note on SEC EDGAR Footnote F3 (shares): Represents RSUs granted as director compensation under the 2022 Plan for board service in fiscal year 2025. The RSUs vest on December 31, 2025, subject to the reporting person's continued service with the issuer through the vesting date.

Recent ONMD Form 8-K filings

Read ONMD company news

Oct 14, 2026Item 8.01

Read the filing on SEC EDGAR

Sep 29, 2026Item 3.03, 5.03, 9.01

Read the filing on SEC EDGAR

Sep 23, 2026Item 5.02, 5.07, 9.01

Read the filing on SEC EDGAR

Jul 24, 2026Item 5.08, 8.01

ONMD insider trading FAQ

What is the latest insider trade for ONMD?

OneMedNet Corp (ONMD) had 6 insider filings in the last 90 days, with the most recent on 14 October 2026. The full record for ONMD runs to 25 Form 4 filings, the earliest from 26 November 2025. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.

How many insiders are buying ONMD stock?

4 insider purchases of ONMD were filed in the last 90 days, totaling $2.09M.

How many insiders are selling ONMD stock?

5 insider sales of ONMD were filed in the last 90 days, totaling $103K.

Where can I see ONMD SEC filings (Form 4, 10-K, 10-Q, 8-K)?

This page collects ONMD Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Health Care companies with insider activity

Recent insider filings

The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.

Oct 14, 2026 - Thomas Kosasa view on EDGAR
Oct 14, 2026 - Jeffrey Yu view on EDGAR
Oct 10, 2026 - Robert Lawrence Golden view on EDGAR
Oct 10, 2026 - Aaron Green view on EDGAR
Sep 15, 2026 - Jeffrey Yu view on EDGAR
Aug 7, 2026 - Thomas Kosasa view on EDGAR
Jun 24, 2026 - Aaron Green view on EDGAR
Jun 24, 2026 - Jeffrey Yu view on EDGAR
Jun 17, 2026 - Jeffrey Yu view on EDGAR

Related companies with recent insider activity

Learn more

How to read insider buying signals: What an open-market purchase by an insider can and cannot tell you.
Insider activity in Health Care: Where ONMD's peers are being bought and sold.
Every recent Form 4: The market-wide feed, updated as filings arrive from SEC EDGAR.

Follow ONMD with a 7-day demo

ONMD on your watchlist
Every ONMD Form 4 filing on record
Up to 3 months of ONMD price history
The daily trading plan of ranked insider buys, on a delay, with the plan archive

Start 7-day demoCard required. Your card is never charged for the demo.

Form 4 transaction type

Transactions

Total value

Open-market purchase

1,767,016

$2.09M

Open-market sale

15,167

$103K

Grant or award

110,000

Traded

Insider

Transaction

Security

Price

Value

Oct 7, 2026

Thomas Kosasa - Director

Open-market purchase

Common Stock

129,758

$5.78^{footnote F2}

$750K

Footnote F2 (price): The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date.

Oct 9, 2026